Royal Marsden NHS Foundation Trust

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website: http://www.royalmarsden.nhs.uk

Clinical Trials

The HeartSpare Study (Stage I)

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Procedure: Voluntary deep-inspiratory breath hold
Procedure: Prone treatment
Device: Active-breathing-controlled deep-inspiratory breathhold

First Posted Date: 2016-06-09

Last Posted Date: 2016-06-09

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 57

Registration Number: NCT02794324

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

Primary Radiotherapy And DIEP flAp Reconstruction Trial

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Other: Radiotherapy before surgery

First Posted Date: 2016-05-13

Last Posted Date: 2022-05-02

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 33

Registration Number: NCT02771938

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom

The HeartSpare Plus 1B Trial

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Radiation: VMAT_FB
Radiation: WT_vDIBH

First Posted Date: 2016-05-13

Last Posted Date: 2022-04-19

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 39

Registration Number: NCT02771353

Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases

Phase 2

Active, not recruiting

Conditions: Carcinoma, Non-Small-Cell Lung
Prostate Cancer
Breast Cancer

Interventions: Other: Standard of Care
Radiation: SBRT

First Posted Date: 2016-05-03

Last Posted Date: 2019-08-21

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 245

Registration Number: NCT02759783

Locations: 🇬🇧
The Christie Hospital, Manchester, United Kingdom
🇬🇧
Queen Elizabeth Hospital, Birmingham, United Kingdom
🇦🇺
Calvary Mater Newcastle, Waratah, New South Wales, Australia

and more 26 locations

Tenovus Cancer Choirs Study: the Benefits of Singing for Those Affected by Cancer

Not Applicable

Conditions: Cancer

Interventions: Other: Tenovus Cancer Choir

First Posted Date: 2016-04-29

Last Posted Date: 2016-04-29

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 420

Registration Number: NCT02756780

Locations: 🇬🇧
Royal Marsden Hospital NHS Foundation Trust, London/Surrey, United Kingdom

Developing a Symptom List for Children With Cancer

Conditions: Paediatric Oncology Palliative Care

First Posted Date: 2016-04-04

Last Posted Date: 2016-04-04

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 40

Registration Number: NCT02726815

Locations: 🇬🇧
Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

Art Therapy for Pain Relief in Breast Cancer Patients

Conditions: Pain

Interventions: Other: Art Therapy Group

First Posted Date: 2016-02-11

Last Posted Date: 2018-05-01

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 20

Registration Number: NCT02680236

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom

Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy Trial

Phase 2

Recruiting

Conditions: Adenocarcinoma of the Stomach
Adenocarcinoma of the Oesophagus
Adenocarcinoma of the Gastro-oesophageal Junction

Interventions: Drug: Trastuzumab
Drug: Rucaparib
Drug: Capecitabine
Drug: MEDI4736 (Durvalumab)
Drug: Ramucirumab

First Posted Date: 2016-02-09

Last Posted Date: 2023-05-15

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 924

Registration Number: NCT02678182

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Sutton, United Kingdom

A Study of Anti-PD-1 (Pembrolizumab) Therapy in Metastatic Melanoma (ADAPTeM)

Phase 2

Withdrawn

Conditions: Advanced Melanoma

Interventions: Drug: Pembrolizumab

First Posted Date: 2016-01-26

Last Posted Date: 2017-08-01

Lead Sponsor: Royal Marsden NHS Foundation Trust

Registration Number: NCT02663258

Using an Electronic Nose to Predict Gastrointestinal Consequences of Pelvic Radiotherapy

Conditions: Toxicity
Malignancy
Cancer

First Posted Date: 2016-01-07

Last Posted Date: 2018-01-30

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 120

Registration Number: NCT02649491

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy